NCT07088328View on ClinicalTrials.gov

Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

March 2, 2026

Conditions
Hypoxic-Ischemic EncephalopathyNeonatal EncephalopathyPentoxifylline Adverse Reaction
Interventions
DRUG

Pentoxifylline

Intravenous administration for 3 days

OTHER

placebo distilled water

Intravenous administration for 3 days

All Listed Sponsors
lead

Alexandria University

OTHER